Key facts
- Notable investors include Lin Nan Capital, Xin Ding Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Hejia Pharmatech
- ·The full record, as it builds
Funding rounds
No funding rounds for Hejia Pharmatech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hejia Pharmatech
Manufacturer of chemical compounds intended for pharmaceutical, industrial, and specialty applications. The company offers pharmaceutical intermediates such as active esters and acids for cephalosporin synthesis, raw materials like sodium salts of antibiotics, and fine chemicals including surfactants, polyols, and catalysts, enabling pharmaceutical and industrial markets to access a broad portfolio of synthesis-ready inputs, formulation components, and process enhancers for scalable production and specialized use cases.
- Sector
- Materials and Resources
- HQ
- Shijiazhuang, China
- Founded
- 1999
- Employees
- 547
- Website
- hejia-china.com/
- Ownership
- Privately Held (backing)
Hejia Pharmatech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hejia Pharmatech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hejia Pharmatech in its N-PORT filings yet. We sweep new filings monthly.